Precision Optics Corporation (POCI) Cash from Financing Activities (2011 - 2026)
Precision Optics Corporation (POCI) posted quarterly Cash from Financing Activities of $10.5 million for Q1 2026, up 143.66% year-over-year from $4.3 million in Q1 2025, and up 6719.76% quarter-over-quarter from -$158198.0 in Q4 2025.
Precision Optics Corporation (POCI) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has reported Cash from Financing Activities for 16 consecutive years, with $10.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 143.66% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $10.0 million (up 74.86% YoY), while the FY2025 annual figure was $5.1 million, up 1028.44% from the prior year.
- Cash from Financing Activities climbed to $10.5 million in Q1 2026 per POCI's latest filing, from -$158198.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $10.5 million in Q1 2026 and bottomed at -$269019.0 in Q2 2022.
- Historically, Cash from Financing Activities has averaged $1.1 million across 5 years, with a median of -$101097.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 374.57% — and 2025, when it surged 1531.07%.
- Precision Optics Corporation's Cash from Financing Activities stood at -$101097.0 in 2022, then slumped by 34.86% to -$136336.0 in 2023, then surged by 390.21% to $395664.0 in 2024, then plunged by 139.98% to -$158198.0 in 2025, then soared by 6719.76% to $10.5 million in 2026.
- Business Quant data shows POCI's Cash from Financing Activities at $10.5 million in Q1 2026, -$158198.0 in Q4 2025, and -$158068.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Precision Optics Corporation | 35.46 Mn | 24.78 Mn | 2.06 Mn | 10.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.47 Mn |
| Mar 31, 2026 | 10.47 Mn |
| Dec 31, 2025 | -158,198.00 |
| Dec 31, 2025 | -158,198.00 |
| Sep 30, 2025 | -158,068.00 |
| Sep 30, 2025 | -158,068.00 |
| Jun 30, 2025 | -121,267.00 |
| Jun 30, 2025 | -121,267.00 |
| Mar 31, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | 395,664.00 |
| Dec 31, 2024 | 395,664.00 |
| Sep 30, 2024 | 577,015.00 |
| Sep 30, 2024 | 577,015.00 |
| Jun 30, 2024 | 468,030.00 |
| Jun 30, 2024 | 468,030.00 |
| Mar 31, 2024 | 263,503.00 |
| Mar 31, 2024 | 263,503.00 |
| Dec 31, 2023 | -136,336.00 |
| Dec 31, 2023 | -136,336.00 |